title: Re: Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
authors.affiliation: *Ophthalmology Service, Sarikamis Military Hospital, Kars, Turkey †Ophthalmology Service, Agri Military Hospital, Agri, Turkey ‡Ophthalmology Service, Erzurum Military Hospital, Erzurum, Turkey §Department of Ophthalmology, GATA Medical School, Ankara, Turkey.
authors.forename: Ümit
authors.initials: Ü
authors.lastname: Yolcu
authors.forename: Ahmet
authors.initials: A
authors.lastname: Tas
authors.forename: Abdullah
authors.initials: A
authors.lastname: Ilhan
authors.forename: Salih
authors.initials: S
authors.lastname: Altun
authors.forename: Fatih C
authors.initials: FC
authors.lastname: Gundogan
mesh_terms: D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012160:Retina / Q000503:physiopathology*; D012170:Retinal Vein Occlusion / Q000188:drug therapy*; D014792:Visual Acuity / Q000502:physiology*; D014822:Vitreous Body / Q000187:drug effects*
chemical_list: D005938:Glucocorticoids; D003907:Dexamethasone